SRS278 - Analysing the impact of a consultant-led treat-to-target approach to lipid-lowering therapy in abdominal aortic aneurysm (AAA) patients
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Abstract Introduction Abdominal aortic aneurysms (AAAs) affect ∼4% of men aged 65–74 and carry substantial cardiovascular risk. Elevated low-density lipoprotein cholesterol (LDL-C) drives atherosclerosis, with each 1 mmol/L reduction lowering major adverse cardiac events (MACE). Despite statins being effective, fewer than 60% of AAA surveillance patients receive therapy. Guidelines recommend intensive lipid-lowering, with targets of
Fields of Study & Subjects
Lipoproteins and Cardiovascular Health
Aortic aneurysm repair treatments
Blood Pressure and Hypertension Studies
Publication details
- Journal / source
- British journal of surgery
- Volume
- 113
- Issue
- Supplement_2
- Publication date
- 1 March 2026
- Language
- EN